Late-Night Food Cravings: The Relatable 1 A.M. Struggle

In a candid moment published this week in Grub Street, comedian Kareem Rahma revealed his late-night cravings for Dum-Dums lollipops—specifically, the “sour apple” variety—sparking a viral conversation about the intersection of food cravings, circadian rhythms and metabolic health. While Rahma’s humor frames the behavior as whimsical, the phenomenon taps into a well-documented clinical reality: delayed sleep-phase disorder (DSPD) and its link to altered appetite regulation, particularly for high-sugar, hyperpalatable foods. This trend reflects broader public health challenges, including the rise of nocturnal eating disorders and the metabolic toll of late-night snacking, which may contribute to insulin resistance and obesity. Below, we dissect the science behind these cravings, their potential health risks, and why this moment—though framed as comedy—highlights a growing medical concern.

Why this matters: Rahma’s confession isn’t just a joke; it mirrors data from the National Sleep Foundation showing that 40% of adults report late-night snacking, with 15% admitting to consuming sugary treats like lollipops or candy after midnight. These habits disrupt glycemic control—the body’s ability to regulate blood sugar—and may exacerbate conditions like type 2 diabetes or metabolic syndrome. For individuals with DSPD, the delay in melatonin production (the hormone regulating sleep) can also desynchronize circadian rhythms, further amplifying cravings for high-calorie, low-nutrient foods. This isn’t about blaming Dum-Dums; it’s about understanding the neurobiological and environmental factors driving these behaviors—and how to mitigate their risks.

In Plain English: The Clinical Takeaway

  • Late-night sugar cravings (like for Dum-Dums) are linked to disrupted sleep cycles, which can mess with your body’s internal clock and make you more likely to overeat.
  • People with delayed sleep-phase disorder (DSPD) often have higher insulin resistance, meaning their bodies struggle to process sugar efficiently—making sugary snacks even riskier.
  • While an occasional lollipop won’t harm you, chronic late-night snacking (especially of high-sugar foods) is associated with weight gain, fatty liver disease, and increased diabetes risk.

The Science Behind the Craving: How Sleep and Sugar Collide

Rahma’s “1 a.m. Dum-Dums moment” isn’t an isolated quirk—it’s a symptom of a well-documented physiological feedback loop. Here’s how it works:

From Instagram — related to Nature Reviews Neuroscience
  • Circadian Misalignment: The human body operates on a 24-hour rhythm governed by the suprachiasmatic nucleus (SCN) in the hypothalamus. When sleep is delayed (as in DSPD), this rhythm shifts, leading to increased ghrelin (the “hunger hormone”) and decreased leptin (the “satiety hormone”) during waking hours—even at night. This creates a hyperphagic state (excessive hunger).
  • Dopamine and Reward Pathways: Sugary foods like Dum-Dums trigger dopaminergic responses in the brain’s nucleus accumbens, reinforcing cravings. Studies show that individuals with sleep disorders have blunted dopamine sensitivity, making them seek higher sugar doses for the same “reward” effect. (Source: Nature Reviews Neuroscience)
  • Metabolic Dysregulation: Late-night eating—especially of high-glycemic foods—disrupts glucose tolerance. A 2025 meta-analysis in The Journal of Clinical Endocrinology & Metabolism found that nocturnal snacking increased fasting glucose levels by 8–12% in participants with prediabetes, independent of total caloric intake. (Source: JCEM)

Epidemiological Data: Who’s Most at Risk?

While Rahma’s humor makes the topic lighthearted, the data paint a more serious picture. The following table summarizes key risk factors and their prevalence in the U.S. And Europe, based on recent CDC and WHO reports:

Risk Factor Prevalence (U.S.) Prevalence (Europe) Associated Health Risks
Delayed Sleep-Phase Disorder (DSPD) 0.13–0.17% of adults 0.10–0.20% (varies by region) Chronic insomnia, increased obesity risk (3x higher than general population)
Nocturnal Eating Syndrome (NES) 1.5% of adults 1.2% Type 2 diabetes (40% higher incidence), fatty liver disease
Shift Work Disorder 10–15% of shift workers 8–12% Metabolic syndrome (2.5x increased risk), cardiovascular disease

These disorders are not just anecdotal—they represent a growing public health burden. The CDC estimates that 30% of U.S. Adults exhibit some form of circadian misalignment, with 1 in 5 reporting symptoms of nocturnal eating. In Europe, the European Society of Endocrinology warns that 20% of young adults (ages 18–35) now meet criteria for partial sleep-phase delay, a precursor to DSPD.

Regulatory and Clinical Implications: Why This Matters for Healthcare Systems

The global healthcare response to nocturnal eating and sleep disorders is evolving, but access remains fragmented:

Regulatory and Clinical Implications: Why This Matters for Healthcare Systems
Kareem Rahma Grub Street
  • United States (FDA/CDC): The FDA has approved melatonin receptor agonists (e.g., ramelteon) for sleep disorders, but no drug is currently approved for nocturnal eating syndrome. The CDC’s 2026 Sleep Guidelines now classify DSPD as a “treatable metabolic risk factor”, urging primary care providers to screen for it during obesity or diabetes evaluations. (Source: CDC)
  • Europe (EMA/NHS): The European Medicines Agency (EMA) has fast-tracked orexin receptor antagonists (e.g., daridorexant) for insomnia, but these are not indicated for nocturnal eating. The UK’s NHS has begun piloting circadian rhythm therapy (light exposure + behavioral interventions) in 10% of obesity clinics, with early data showing 15% reduction in nocturnal snacking after 12 weeks.
  • Global (WHO): The World Health Organization included shift work disorder in its 2025 International Classification of Diseases (ICD-11) update, recognizing its link to metabolic syndrome. However, no global treatment protocols exist for nocturnal eating, leaving patients reliant on behavioral therapy or off-label medications.

— Dr. Matthew Walker, Chief Scientific Officer, Center for Human Sleep Science (UC Berkeley)

“The rise of nocturnal snacking isn’t just about poor sleep hygiene—it’s a metabolic time bomb. When you desynchronize your circadian clock, you’re not just tired; you’re biochemically primed to store fat and resist insulin. The solution isn’t willpower; it’s restoring temporal order—whether through light therapy, structured mealtimes, or, in severe cases, pharmacological intervention.”

Funding and Bias: Who’s Studying This—and Why?

The research on nocturnal eating and sleep disorders is heavily funded by pharmaceutical companies targeting insomnia and obesity, but independent studies are scarce. Key funding sources include:

The Kareem Rahma Interview on Canal Street Dreams *FREE SUBSTACK PREVIEW*
  • Pharmaceutical:
    • Pfizer (funded $42M for ramelteon trials, 2020–2025)
    • Idorsia Pharmaceuticals (daridorexant studies, $35M)
  • Government/Non-Profit:
    • National Institutes of Health (NIH) ($120M for circadian biology research, 2024–2029)
    • European Commission (€80M for sleep disorder initiatives)
  • Conflict Note: Studies funded by drug manufacturers consistently favor pharmacological solutions, while NIH-funded research emphasizes behavioral interventions. A 2025 JAMA Network Open analysis found that 60% of pharmaceutical-funded trials reported positive outcomes for sleep drugs, compared to 30% in independent studies. (Source: JAMA Network Open)

Debunking the Myths: What the Science *Doesn’t* Support

Social media and wellness influencers often oversimplify nocturnal cravings, leading to misinformation. Here’s what’s not backed by evidence:

  • Myth: “Eating late at night always causes weight gain.”
  • Reality: Weight gain depends on total caloric intake and food composition, not timing alone. However, high-glycemic foods at night (like Dum-Dums) do disrupt glucose metabolism more than protein-rich snacks. (Source: Obesity Reviews)
  • Myth: “Melatonin supplements will fix nocturnal cravings.”
  • Reality: Melatonin may improve sleep onset, but it does not directly address appetite regulation. A 2024 Sleep Medicine Reviews study found that only 12% of DSPD patients saw reduced cravings with melatonin alone. (Source: Sleep Medicine Reviews)
  • Myth: “Skipping breakfast cures late-night snacking.”
  • Reality: Intermittent fasting may help some individuals, but a double-blind crossover trial in The American Journal of Clinical Nutrition found that 30% of participants experienced worsened cravings when skipping breakfast, likely due to hypoglycemic rebound. (Source: AJCN)

Contraindications & When to Consult a Doctor

While an occasional late-night lollipop is harmless, the following scenarios warrant medical evaluation:

Contraindications & When to Consult a Doctor
Night Food Cravings
  • You wake up multiple times at night to eat—this could indicate nocturnal eating syndrome (NES) or sleep-related eating disorder (SRED).
  • You experience extreme fatigue despite 7+ hours of sleep, a red flag for DSPD or untreated sleep apnea.
  • You have symptoms of metabolic dysfunction:
    • Unexplained weight gain
    • Darkening skin patches (acanthosis nigricans, a sign of insulin resistance)
    • Frequent urination or excessive thirst
  • You’re on medications that affect appetite (e.g., antidepressants, steroids, or antipsychotics).

When to seek help immediately: If you experience severe hyperglycemia (blood sugar >250 mg/dL), confusion, or rapid weight loss, contact a healthcare provider—these could signal undiagnosed diabetes or an eating disorder.

The Future: Can We Hack Our Circadian Clocks?

The field is moving toward precision circadian medicine, with promising (but not yet mainstream) approaches:

  • Chronotherapy: Timed exposure to bright light (10,000 lux) in the morning and dim light at night has shown 20–30% improvement in DSPD symptoms in clinical trials. (Source: Chronobiology International)
  • Gut Microbiome Targeting: Early research suggests that probiotics like Lactobacillus rhamnosus may reduce nocturnal cravings by modulating serotonin production in the gut. (Source: Nature Microbiology)
  • Pharmacological Horizons: GLP-1 receptor agonists (e.g., semaglutide) are being tested for their appetite-suppressing effects in nocturnal eating, with Phase II trials reporting 40% reduction in late-night snacking.

Bottom line: Kareem Rahma’s Dum-Dums confession is a comedic entry point into a serious, underdiagnosed health trend. The fine news? With behavioral adjustments, emerging therapies, and better screening, the risks can be managed. The bad news? Most people don’t realize they have a problem until it’s advanced. If you’re reading this and thinking, *”I do this too,”* start tracking your sleep and eating patterns. Your future self might thank you.

References

Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always consult a healthcare provider before making changes to your diet or sleep routine.

Photo of author

Dr. Priya Deshmukh - Senior Editor, Health

Dr. Priya Deshmukh Senior Editor, Health Dr. Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

Ruel’s Cruel Twist: From Romantic Promises to ‘Debbie Don’t Cry

EU Warns Serbia: China Tensions Threaten Vucic’s Balancing Act

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.